References
- BhullarSPhillipsBSleep in COPD patientsCOPD20052335536117147000
- LangePMarottJLVestboJNordestgaardBGPrevalence of night-time dyspnoea in COPD and its implications for prognosisEur Respir J20144361590159824488571
- AgustiAHednerJMarinJMBarbeFCazzolaMRennardSNight-time symptoms: a forgotten dimension of COPDEur Respir Rev20112012118319421881146
- PartridgeMRKarlssonNSmallIRPatient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet surveyCurr Med Res Opin20092582043204819569976
- European Medicines Agency Respiratory Drafting GroupGuideline on clinical investigation of medicinal products in the treatment of chronic obstructive pulmonary disease (COPD)EMA/CHMP/483572/2012 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/08/WC500130880.pdfAccessed December 8, 2014
- US Food and Drug AdministrationGuidance for industry on patient-reported outcome measures: use in medical product development to support labeling claimsFed Reg2009746513265133
- StullDELeidyNKParasuramanBChassanyOOptimal recall periods for patient-reported outcomes: challenges and potential solutionsCurr Med Res Opin200925492994219257798
- HareendranAPalsgroveACMocarskiMThe development of a patient-reported outcome measure for assessing nighttime symptoms of chronic obstructive pulmonary diseaseHealth Qual Life Outcomes20131110423799883
- D’UrzoARennardSKerwinEMergelVLeselbaumACaractaCEfficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD studyRespir Res201415112325756831
- FayersPHaysRAssessing Quality of Life in Clinical TrialsNew YorkOxford University Press2005
- StreinerDL NGHealth Measurement Scales: A Practical Guide to their Development and Use4th edNew YorkOxford University Press2008
- European Medicines Agency (EMEA) Committee for Medicinal Products for Human Use (CHMP)Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003637.pdfAccessed December 8, 2014
- MahlerDADyspnea: Mechanisms, Measurement, and Management3rd edBoca Raton, FLCRC Press2014
- LeidyNKSextonCCJonesPWMeasuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diaryThorax2014695424430
- JonesPWQuirkFHBaveystockCMLittlejohnsPA self-complete measure of health status for chronic airflow limitation: the St George’s Respiratory QuestionnaireAmer Rev Respir Dis19921456132113271595997
- MahlerDAWellsCKEvaluation of clinical methods for rating dyspneaChest19889335805863342669
- LeidyNKWilcoxTKJonesPWDevelopment of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): a patient-reported outcome (PRO) measureValue Health201013896597520659270
- JonesPWQuirkFHBaveystockCMThe St George’s Respiratory QuestionnaireRespir Med199185Suppl. B2531 discussion 33–271759018
- MahlerDAWeinbergDHWellsCKFeinsteinARThe measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexesChest19848567517586723384
- JunghardOLauritsenKTalleyNWiklundIValidation of seven graded diary cards for severity of dyspeptic symptoms in patients with non ulcer dyspepsiaEur J Surg1998164Suppl 583106111
- BentlerPMComparative fit indexes in structural modelsPsychol Bul19901072238246
- LJCCoefficient alpha and the internal structure of testsPsychometrika195116297334
- NunnallyJC BIPsychometric Theory3rd edNew YorkMcGraw-Hill1994
- ReddellHKTaylorDRBatemanEDAn official American Thoracic Society/European Respiratory Society Statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practiceAm J Respir Crit Care Med20091801599919535666
- NishimuraKIzumiTTsukinoMOgaTDyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPDChest200212151434144012006425
- CohenJStatistical Power Analysis for the Behavioral SciencesHillsdale, NJLawrence Erlbaum Associates1988
- StewartALHaysRDWareJEMethods of Validating MOS Health MeasuresDurham, NCDuke University Press1992
- HaysRDRevickiDReliability and Validity (Including Responsiveness)2nd edNew York, NYOxford University Press2005